Chairman of the Department of Mental Health and General Psychiatry Residency Training Program at the University of Siena, Italy.
In 1998 he became a member of the University of Pittsburgh (USA), where he held the positions of Assistant Professor, Associate Professor, Medical Director of the Center for Bipolar Disorder and Medical Director of the Center for the Prevention and Treatment of Depression and of the Manic Depressive Illness. More recently, he moved to the University of Siena where he serves as Professor of Psychiatry and Chief of Psychiatry Clinical Services. He is the author of more than 300 book chapters and papers in international journals. The topics of his research focus on the pharmacological treatment of mood, psychotic and anxiety disorders, the quality of life in patients with psychiatric illness and the strategies to improve the outcome of mental disorders through improved lifestyle.
Il 2017 segna il ritorno della SOPSI a Roma nella sua storica sede dell’Hilton, oggi Cavalieri Waldorf Astoria, dove dal 22 al 25 febbraio 2017 si è svolto il XXI Congresso Nazionale della Società Italiana di Psicopatologia, dal titolo: Progetto Promozione Salute Mentale 20.20. “Psicopatologia: cambiamenti, confini, limiti”.
Intervista al prof. Fagiolini, un'overview riguardo il trattamento, la diagnosi e la neurobiologia. Le novità sull'approccio al paziente affetto da schizofrenia. L'utilizzo precoce dei farmaci Long Acting Injectable (LAI) garantisce un miglior outcome di trattamento per questo tipo di pazienti.